Public Offer Pricing and Updates of Financial Companies - Analyst Notes on Ares Capital, NASDAQ OMX, American Capital Mortgage, AEGON and Ally

NEW YORK, May 22, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Ares Capital Corporation (NASDAQ: ARCC), Nasdaq OMX Group Inc. (NASDAQ: NDAQ), American Capital Mortgage Investment (NASDAQ: MTGE), AEGON N.V. (NYSE: AEG) and Ally Financial Inc. (NYSE: ALLY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2800-100free.

Ares Capital Corporation Analyst Notes
On May 19, 2014, Ares Capital Corporation's (Ares Capital) stock increased 0.71%, ending the day at $17.00. Over the previous five trading sessions, shares in Ares Capital increased 2.72%, compared to the Nasdaq Composite which declined 0.44% during the same period. The stock has a 52-week high of $18.63. The full analyst notes on Ares Capital are available to download free of charge at:

http://www.analystsreview.com/2800-ARCC-22May2014.pdf

Nasdaq OMX Group Inc. Analyst Notes
On May 20, 2014, Nasdaq OMX Group Inc. (NASDAQ OMX) declared that it has priced a public offering of $500 million aggregate principal amount of 4.25% senior notes due 2024. Subject to customary closing conditions, the offering is slated to close on May 29, 2014. The Company plans to utilize the aggregate net proceeds from the offering, together with cash on hand, to refinance its 4.00% Senior Notes due 2015 and to finance a portion of the term loan under its senior credit facility. J.P. Morgan Securities LLC and Wells Fargo Securities, LLC are serving as Joint Book-Running Managers for the offering. The offering is being made in accordance with NASDAQ OMX's effective shelf registration statement formerly filed with the SEC and solely by means of a prospectus supplement and accompanying prospectus. The full analyst notes on NASDAQ OMX are available to download free of charge at:

http://www.analystsreview.com/2800-NDAQ-22May2014.pdf

American Capital Mortgage Investment Analyst Notes
On May 15, 2014, American Capital Mortgage Investment Corp. (American Capital Mortgage) declared that it has priced a public offering of 2 million shares of its 8.125% Series A Cumulative Redeemable Preferred Stock, liquidation preference of $25.00 per share, for an approximate gross proceeds of $50 million. The Company also granted the underwriters an option to purchase up to an additional 300,000 shares of Series A Preferred Stock for 30 days after the offering. Slated to close on or about May 22, 2014, the offering is subject to customary closing conditions. The Company plans to utilize the net proceeds from this offering on a leveraged basis to invest in its targeted assets as market conditions warrant, along with agency mortgage investments, non-agency mortgage investments and other mortgage-related investments. Morgan Stanley & Co. LLC and UBS Securities LLC will act as joint book-running managers for the offering, while Citigroup Global Markets Inc. and Deutsche Bank Securities Inc. are acting as joint lead managers. The full analyst notes on American Capital Mortgage are available to download free of charge at:

http://www.analystsreview.com/2800-MTGE-22May2014.pdf

AEGON N.V. Analyst Notes
On May 19, 2014, AEGON N.V.'s (AEGON) stock increased 1.30%, ending the day at $8.55. Over the past month, shares in AEGON declined 3.06%, compared to the Dow Jones Industrial Average which increased 0.63% during the same period. The stock is trading near its 52-week high of $9.50. The full analyst notes on AEGON are available to download free of charge at:

http://www.analystsreview.com/2800-AEG-22May2014.pdf

Ally Financial Inc. Analyst Notes
On May 9, 2014, Ally Financial Inc. (Ally) reported that the underwriters on the Company's initial public offering (IPO) have elected to partially exercise the over-allotment option to purchase an additional of approximately 7.0 million shares of Ally common stock at the IPO price of $25.00. Following the sale of these additional shares, the Company expects the U.S. Department of the Treasury (Treasury) to recover an additional $181 million - bringing the total recovery on the Ally investment to an estimated $17.8 billion. This is an estimated $700 million more than was originally invested in the Company. After the completion of this transaction, Treasury will hold an estimated 16% of the Company's common stock. The full analyst notes on Ally are available to download free of charge at:

http://www.analystsreview.com/2800-ALLY-22May2014.pdf

About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

EDITOR'S NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED